Related Experiment Videos

[The effect of oxedrine on the left ventricle and peripheral vascular resistance]

Arzneimittel-Forschung
|January 1, 1985
PubMed

Insights

Intravenous oxedrine (Sympatol) enhances cardiac performance by increasing left ventricular contractility and cardiac index. This sympathomimetic drug improves heart function economically without raising heart rate.

Area of Science:

  • Cardiovascular Pharmacology
  • Clinical Physiology

Context:

  • Oxedrine (Sympatol), a sympathomimetic agent, interacts with alpha- and beta-adrenergic receptors.
  • Understanding its effects on cardiac function and vascular tone is crucial for clinical applications.

Purpose:

  • To investigate the impact of intravenous oxedrine on cardiac contractility, cardiac index, blood pressure, and peripheral vascular resistance in healthy volunteers.
  • To assess the overall cardiac performance and efficiency under oxedrine infusion.

Summary:

  • Intravenous oxedrine administration (4 mg/min) in 12 healthy males led to significant increases in systolic and mean arterial blood pressure, cardiac index, and left ventricular contractility parameters (shortening fraction and VCFmin).
  • Peripheral vascular resistance significantly decreased, while diastolic blood pressure and heart rate remained unchanged.
  • These findings suggest an economical enhancement of cardiac performance.

Impact:

  • Oxedrine demonstrates a capacity to improve cardiac output and contractility while reducing vascular resistance.
  • The drug's ability to boost cardiac performance without increasing heart rate indicates a potentially efficient cardiovascular support mechanism.

Related Concept Videos